Results 181 to 190 of about 70,562 (248)

Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence. [PDF]

open access: yesJ Transl Med
Surina S   +15 more
europepmc   +1 more source

Diabetic Peripheral Neuropathy: Molecular Staging, Risk Factors, Therapeutics, and Emerging Trends

open access: yesMed Research, Volume 2, Issue 2, Page 309-342, June 2026.
The heterogeneous landscape of DPN can be unified through a tripartite pathogenic model encompassing progressive stages of metabolic dysregulation, chronic inflammation, and overt neuronal damage. Within this framework, six clinical subtypes were identified, namely, hyperglycemia‐driven, dyslipidemia‐driven, inflammation‐driven, dysvascularity‐driven ...
Xiaofeng Dai, Mingze Tang
wiley   +1 more source

Epigenome-wide analysis in West Africans identifies DNA methylation markers for circulating adiponectin. [PDF]

open access: yesEBioMedicine
Mungamba MM   +14 more
europepmc   +1 more source

Does Gum Arabic Alter Gene Expression? Diabetic and Obesity as Models: A Mini Review

open access: yesModern Agriculture, Volume 4, Issue 1, June 2026.
Gum Arabic (GA) modulates obesity‐ and diabetes‐related gene expression, reducing pro‐inflammatory cytokines (IL‐6, TNF‐α, IL‐1β) and increasing IL‐10. GA elevates pAMPK, pACC, and GLP‐1 while decreasing FASN and leptin, indicating improved energy and lipid metabolism. Oxidative stress markers (SOD, GPx, CAT) rise with GA, alongside increased GLUT3 and
Saber Y. Adam   +4 more
wiley   +1 more source

Obesity‐ and Glucose‐Dependent Differential Autophagy Marker Expression in Adipose Tissues and Adipocytes

open access: yesObesity Science &Practice, Volume 12, Issue 3, June 2026.
ABSTRACT Background Autophagy is an evolutionarily highly conserved process and plays an important role in cellular homeostasis and metabolism. In obesity and obesity‐associated insulin resistance, both enhanced and suppressed autophagy have been observed in adipose tissues (AT).
Edita Islami   +5 more
wiley   +1 more source

Impact of Obesity on Systemic Treatment Outcomes in Metastatic Urological Malignancies

open access: yesObesity Science &Practice, Volume 12, Issue 3, June 2026.
ABSTRACT Introduction Obesity increasingly influences treatment outcomes in urological malignancies (metastatic bladder cancer (BC), renal cell cancer (RCC), and prostate cancer (PC)). This study evaluated the impact of obesity on survival in patients with major metastatic urological cancers receiving systemic therapy.
A. Handke   +7 more
wiley   +1 more source

Adiponectin and aging: Mechanistic insights, clinical paradox, and therapeutic horizons. [PDF]

open access: yesAgeing Res Rev
McGregor ER   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy